BGI Genomics Co., Ltd, a leading Chinese gene sequencing firm, has reportedly been added to the US Defense Department’s list of Chinese companies subject to an investment ban for Americans. The move follows the company’s collaboration with China’s military to develop prenatal tests, as noted by Reuters.
Background and Implications
The US Pentagon has identified BGI Genomics as part of its efforts to target private sector companies that provide China’s military with access to advanced technologies and expertise. This action is part of a broader strategy to restrict the flow of capital and technology to entities deemed to have ties with China’s military. The initial list, released in June 2021, included 50 companies, such as mobile phone giant Huawei.
Impact on BGI Genomics
The addition of BGI Genomics to the investment ban list is expected to have significant implications for the company’s access to US capital and technology. It underscores the ongoing tensions between the US and China over technology and national security concerns.-Fineline Info & Tech
